Analgesics in Germany

Date: November 6, 2017
Pages: 21
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A671C6DDD65EN
Leaflet:

Download PDF Leaflet

The current performance of analgesics in Germany can be ascribed to common ailments resulting from modern lifestyles, often characterised by a lack of physical activity or malnutrition. Growth is supported by the growing trend towards self-medication, allowing consumers to treat their ailments without visiting a doctor. In addition, older consumers increasingly suffer from diseases that require pain management, including diabetes and cancer, supporting growth. However, increasing health awarenes...

Euromonitor International's Analgesics in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Focus on Healthier Lifestyles Reduces the Growth of Analgesics
With Limited Active Ingredients, Product Positioning Becomes Key
High Loyalty To Well-established Brands
Competitive Landscape
Gsk Consumer Healthcare Benefits From High Brand Loyalty
Product Characteristics of Emerging Ibuprofen Remedies Support Growth
Boehringer Ingelheim's Consumer Healthcare Business Moving To Sanofi
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Continuing Growth for Consumer Health
Healthy Lifestyles and the Ageing Population Have A Tremendous Impact
High Competition Puts the Focus on Innovation and Positioning
Chemists/pharmacies Remains the Leading Distribution Channel in Consumer Health
Forecast Performance Expected To Be More Moderate
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2012-2017
  Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 1 OTC: Switches 2016-2017
Sources
  Summary 2 Research Sources
Skip to top


OTC Triptans in Germany US$ 990.00 Jul, 2012 · 27 pages
Wound Care in Germany US$ 990.00 Nov, 2017 · 19 pages

Ask Your Question

Analgesics in Germany
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: